-transparent.png){kind=logo}
We examined the in vitro activity of linezolid against Clostridium difficile, including isolates with reduced susceptibility to metronidazole or vancomycin. The MIC at which 50% of the isolates were inhibited (MIC50) and MIC90 were 0.5 and 2 microg/ml, respectively (range, 0.03 to 4 microg/ml). MICs were always <or= 4 microg/ml, and thus, all isolates were considered susceptible.
Related Publications
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
March 2003,
The Journal of antimicrobial chemotherapy,
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
May 2001,
The Journal of antimicrobial chemotherapy,
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
June 2004,
Antimicrobial agents and chemotherapy,
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
August 2014,
Anaerobe,
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
May 2012,
International journal of antimicrobial agents,
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
October 2014,
Nutrition (Burbank, Los Angeles County, Calif.),
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
July 2017,
Journal of applied microbiology,
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
April 2004,
Journal of chemotherapy (Florence, Italy),
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
January 2012,
The Journal of hospital infection,
T Peláez, and
R Alonso, and
C Pérez, and
L Alcalá, and
O Cuevas, and
E Bouza
January 2018,
Frontiers in microbiology,
